Approval · Notice of Compliance 33092 · 2024
TEPADINA: Notice of Compliance 33092
Issued April 22, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33092
- Date
- April 22, 2024
- Company
- Adienne SaLugano, Tessin, Switzerland
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of an alternate drug product manufacturer.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEPADINA | Not yet assigned | — |
Medicinal ingredients
- THIOTEPA 400 MG per BAG